SEC Form 10-Q Summary
Filing identity: The supplied filing is for Agrify Corporation (NASDAQ: AGFY), not RYTHM, Inc. It covers the quarter and six months ended June 30, 2022, with unaudited results. Agrify provides cannabis cultivation, extraction, facility build-out, equipment, software, and related services.
Business Context and Reporting Period
Agrify’s revenue is generated from cultivation solutions, Agrify Insights software, facility build-outs, and extraction solutions. The company completed the acquisition of Lab Society on February 1, 2022 and continued integrating the Precision, Cascade, and PurePressure businesses acquired in 2021.
Key Financial Metrics
| Metric | Three Months Ended June 30 | Six Months Ended June 30 |
|---|---|---|
| Revenue | $19.3 million, up 64% | $45.4 million, up 141% |
| Gross profit | $1.6 million; 8.3% margin | $5.8 million; 12.7% margin |
| Operating loss | $91.5 million | $101.3 million |
| Net loss attributable to Agrify | $93.4 million | $102.3 million |
| Loss per share | $3.51 | $4.00 |
| Net cash used in operating activities | Not separately provided | $57.6 million |
Extraction solutions contributed $10.0 million of second-quarter revenue and $22.4 million of first-half revenue, primarily from acquired businesses. Facility build-out revenue was $9.0 million in the quarter and $22.2 million for the first six months. Cultivation solutions revenue declined to $321 thousand in the quarter and $703 thousand year to date.
Gross profit benefited from the higher-margin extraction business but was reduced by $929 thousand of additional slow-moving inventory reserves and $181 thousand of warranty reserves. Management stated that second-quarter gross margin would have been approximately 14.1% absent those charges.
Balance Sheet, Debt, and Liquidity
| Balance Sheet Item | June 30, 2022 | December 31, 2021 |
|---|---|---|
| Cash and cash equivalents | $18.6 million | $12.0 million |
| Restricted cash | $30.0 million | None reported |
| Marketable securities | $11.3 million | $44.6 million |
| Total assets | $171.2 million | $182.0 million |
| Total debt, before discount | $66.7 million | $1.1 million |
| Total liabilities | $93.2 million | $44.6 million |
| Accumulated deficit | $161.3 million | $59.0 million |
Cash, cash equivalents, and marketable securities totaled approximately $29.9 million, plus $30.0 million of restricted cash. Management estimated that available cash would support operations for approximately six to nine months before considering debt restructuring. The company used approximately $30 million per quarter during the preceding two quarters.
The March 2022 SPA Note has $65.0 million of principal, a stated interest rate of 6.75%, and maturity in March 2026. The company was in default of certain financial covenants at June 30, 2022. The lender could require repayment of approximately $75.0 million, including a 115% default penalty and higher default interest. The company had approximately $59.9 million of cash, restricted cash, cash equivalents, and marketable securities, which would not have covered that obligation.
Cash Flow and Material Changes
- Operating cash use increased to $57.6 million from $13.8 million in the comparable 2021 period, reflecting the substantial net loss, increased inventory, receivables, and other working-capital needs.
- Investing cash use was $26.9 million, including $20.4 million of TTK-related loan receivables, $6.4 million of property and equipment purchases, $3.5 million for acquisitions, and net marketable-security purchases.
- Financing activities provided $91.1 million, primarily from $65.0 million of equity and warrant financing and $25.8 million of debt and warrant financing.
- Inventory increased to $41.9 million from $20.5 million, while inventory reserves increased to $1.9 million from $942 thousand.
- The company recorded an $8.6 million increase in receivable allowances, including a $7.1 million reserve against Greenstone-related loan receivables and approximately $1.5 million of additional trade-receivable reserves.
- Goodwill and intangible assets were fully impaired, resulting in a $69.9 million non-cash charge. The impairment followed a decline in market capitalization, weaker-than-expected sales and financial performance, higher expenses, and a cannabis-industry slowdown.
- General and administrative expense increased 341% in the quarter to $19.4 million, driven principally by receivable allowances, acquisition-related costs, personnel and facility costs, and an $800 thousand legal settlement accrual.
Guidance, Outlook, Risks, and Unusual Items
- The filing does not provide formal revenue or earnings guidance. Management expects continued investment in VFUs, Agrify Insights, and extraction products and expects research and development expense to decline as a percentage of revenue as revenue grows.
- Management concluded that substantial doubt exists about the company’s ability to continue as a going concern within twelve months. Continued operations depend on additional debt or equity financing, successful debt restructuring, and eventual improvement in operating cash flow.
- After quarter-end, Agrify reached an agreement in principle with its institutional lender to amend the SPA Note and modify financial covenants. Completion of the amendment was not assured at the filing date.
- COVID-19 continued to cause supply-chain delays, higher operating costs, and increased shipping costs. The cannabis market also experienced a second-quarter slowdown and unfavorable conditions, including in Colorado.
- Customer and related-party concentration is significant. New England Innovation Academy was a related party and represented 23.1% of accounts receivable at June 30, 2022; the filing indicates no customer exceeded 10% of second-quarter revenue.
- The company accrued approximately $800 thousand for a tentative settlement of litigation involving former employees. U.S. Customs seized grow lights appraised at approximately $623 thousand; Agrify plans to dispute the seizure.
- Disclosure controls were not effective as of June 30, 2022 because of previously identified material weaknesses in internal control over financial reporting. Management is implementing remediation measures.
- On August 10, 2022, the company entered into a post-closing settlement with Sinclair involving $5.6 million of contingent consideration, payable through $3.3 million in cash and 87,039 common shares, subject to the agreement’s terms.
Most Important Facts to Verify
- Confirm that the intended issuer is Agrify Corporation rather than RYTHM, Inc.; the supplied filing identifies Agrify Corporation throughout.
- Verify completion and terms of the SPA Note covenant amendment and whether the lender waived or preserved the June 30 default.
- Assess liquidity after the reported $57.6 million first-half operating cash burn, including the availability of restricted cash and expected financing needs.
- Review the recoverability of the remaining loan receivables, particularly the $7.1 million Greenstone allowance and related-party exposure.
- Evaluate the sustainability and margins of acquired extraction revenue relative to lower-margin cultivation and build-out activities.
- Monitor the material weakness remediation, litigation settlement, customs seizure, contingent consideration, and potential dilution from approximately 10.1 million outstanding warrants and 3.3 million stock options.